Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma

CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser… - Gut, 2019 - gut.bmj.com
Background and aims Chronic inflammation induced by chronic hepatitis B virus (HBV) infection
increases the risk of hepatocellular carcinoma (HCC). However, little is known about the …

[HTML][HTML] Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC

…, CA Dutertre, HLH Lai, M Wasser, C Chua… - …, 2022 - Wiley Online Library
Background and Aims Hypoxia is one of the central players in shaping the immune context
of the tumor microenvironment (TME). However, the complex interplay between immune cell …

Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses

…, L Pan, CJ Lim, J Li, R Ong, C Chua… - Proceedings of the …, 2017 - National Acad Sciences
The recent development of immunotherapy as a cancer treatment has proved effective over
recent years, but the precise dynamics between the tumor microenvironment (TME), …

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

V Chew, YH Lee, L Pan, NJM Nasir, CJ Lim, C Chua… - Gut, 2019 - gut.bmj.com
Objectives Yttrium-90 (Y90)-radioembolisation (RE) significantly regresses locally advanced
hepatocellular carcinoma and delays disease progression. The current study is designed to …

[HTML][HTML] Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling

P Kumar, A Lim, SN Hazirah, CJH Chua, A Ngoh… - Nature …, 2022 - nature.com
Epileptogenic triggers are multifactorial and not well understood. Here we aimed to address
the hypothesis that inappropriate pro-inflammatory mechanisms contribute to the …

[HTML][HTML] Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma

…, S Suthen, S A'Azman, G Gien, CJ Lim, C Chua… - Journal of …, 2022 - Elsevier
Background & Aims While immune checkpoint blockade (ICB) has shown promise in patients
with hepatocellular carcinoma (HCC), it is associated with modest response rates and …

Ex vivo–expanded but not in vitro–induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the …

M Rossetti, R Spreafico, S Saidin, C Chua… - The Journal of …, 2015 - journals.aai.org
Regulatory T cell (Treg) therapy is a promising approach for transplant rejection and severe
autoimmunity. Unfortunately, clinically meaningful Treg numbers can be obtained only upon …

[HTML][HTML] Neutralizing activity and SARS-CoV-2 vaccine mRNA persistence in serum and breastmilk after BNT162b2 vaccination in lactating women

…, CJH Chua, S Albani, LF Wang, MC Chua - Frontiers in …, 2022 - frontiersin.org
Background There is limited information on the functional neutralizing capabilities of breastmilk
SARS-CoV-2-specific antibodies and the potential adulteration of breastmilk with vaccine …

TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis

…, A Consolaro, JY Leong, C Chua… - Annals of the …, 2017 - ard.bmj.com
Objectives The imbalance between effector and regulatory T (Treg) cells is crucial in the
pathogenesis of autoimmune arthritis. Immune responses are often investigated in the blood …

[HTML][HTML] Immunological hallmarks for clinical response to BCG in bladder cancer

…, P Kumar, YH Lee, NJM Nasir, C Chua… - Frontiers in …, 2021 - frontiersin.org
Intravesical Bacillus Calmette-Guerin (BCG) is an effective immunotherapy for non-muscle
invasive bladder cancer (NMIBC). However, recurrence and progression remain frequent …